$SCHW — AVOID 📊 | 6 MONTHS THESIS

$SCHW — AVOID 📊 | 6 MONTHS THESIS 🎯 Q1 2026 | Rev $6.2B | EPS $1.43 vs $1.40 🟢 💡 Consensus expects continued growth and EPS beats, but the market underestimates the vulnerability to multiple compression if deposit costs rise or net interest income growth slows, given the premium valuation. 📉 Reward/risk: 0.1:1 🏢 Business Quality: 9/10 - Dominant brokerage with sticky client base, strong brand, and scale advantages generating robust returns. 📊 Valuation: rich - P/E 17.9x trailing, 14.8x forward vs peer base 12.3x; FCF yield 4.7% is decent but not enough to compensate for multiple risk; priced above... 🔮 Catalyst: No imminent catalyst; recent earnings report already digested 💰 Entry: $91.0, stop $86.0, target $88.79 📊 Our read: AVOID. Full analysis → https://stockduty.xyz/s/SCHW0612

🎯 Q1 2026 | Rev $6.2B | EPS $1.43 vs $1.40 🟢